Related Experiment Video

Updated: Jul 22, 2026

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

Phase II study of pyrazoloacridine in metastatic renal cell carcinoma

J P Kuebler1, G W King, P Triozzi

  • 1Grant/Riverside Hospital, Columbus, OH, USA.

Investigational New Drugs
|September 20, 2001
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Related Experiment Videos

Last Updated: Jul 22, 2026

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...

Articles linked to this work by shared authors, journal, and citation graph.

Using motion capture technology to measure the effects of magnification loupes on dental operator posture: A pilot study.

Work (Reading, Mass.)·2018

Quantitative aspects of the clinical performance of transverse tripolar spinal cord stimulation.

Neuromodulation : journal of the International Neuromodulation Society·2011

Clinical and immunological effects of a synthetic Beta-human chorionic-gonadotropin vaccine.

International journal of oncology·2011

Experimental study of intracranial hematoma detection with flat panel detector C-arm CT.

AJNR. American journal of neuroradiology·2008

Phase II clinical trial of arsenic trioxide with liposomal doxorubicin, vincristine, and dexamethasone in newly diagnosed multiple myeloma.

Leukemia research·2007

Surgical interventions in a cohort of patients with haemophilia A and inhibitors: an experiential retrospective chart review.

Haemophilia : the official journal of the World Federation of Hemophilia·2007

First-in-human phase I study of DT-9081, a selective EP4 receptor antagonist, in advanced solid tumors.

Investigational new drugs·2026

Qishen Yiqi Dripping Pills ameliorate doxorubicin-induced cardiotoxicity: a study based on bioinformatics and experimental verification.

Investigational new drugs·2026

Influence of LGALS3 polymorphisms on chemotherapy-induced peripheral neuropathy in patients with metastatic pancreatic cancer treated with gemcitabine and nab-paclitaxel: an exploratory biomarker analysis of the GENESECT study.

Investigational new drugs·2026

Inhibition of SHP2 enhances the effects of selective receptor tyrosine kinase inhibitors in untreated preclinical models of RET-mutated thyroid cancer.

Investigational new drugs·2026

Novel EGFR tyrosine kinase inhibitors exhibiting intrinsic fluorescence.

Investigational new drugs·2026

The novel agent VP79s synergistically enhances venetoclax activity in multiple myeloma cells.

Investigational new drugs·2026

Type I interferons modulate autophagy to shape gemcitabine response in pancreatic cancer cells.

FEBS open bio·2026

Breaking barriers in cancer pain management: a report from the National Week Against Cancer Pain in Argentina 2025.

Ecancermedicalscience·2026

Network pharmacology and experimental evidence of the anti-colorectal cancer potential of Xian Lian Jie Du formula: quercetin, kaempferol and luteolin jointly inhibit the HIF1A/IL6/TNF oncogenic pathway.

Frontiers in oncology·2026

EZH2 Expression and Clinical Outcomes in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: A Real-World Retrospective Cohort Study.

Journal of clinical medicine·2026

The Immune Landscape of Chondrosarcoma: A Review of Tumor-Related Immune Cells.

Cancers·2026

Neurofilament Light Chain: A Potential Biomarker for Chemotherapy-Induced Peripheral Neuropathy in Pediatric and Adolescent Young Adults with Leukemia or Lymphoma.

Cancers·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us